reports
Greenwich LifeSciences Announces Partnership with GBG in Germany for F...
Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01 STAFFORD, Texas, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the initiation of clinical sites in Germany. The Company has partnered with GBG (German Breast Group), the largest academic breast cancer research network in Germany, where approximately 38 sites have ag...
- Jonathan Moreland
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 i...
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France STAFFORD, Texas, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the activation of clinical sites in France. According to the latest data collected by the European Cancer Information System (), a total of 66,328 new cases of breast cancer were diagnosed in France in ...
- Jonathan Moreland
OXY OCCIDENTAL PETROLEUM CORPORATION
VRSN VERISIGN INC.
OMEX ODYSSEY MARINE EXPLORATION INC.
LNDC LANDEC CORP.
FPI FARMLAND PARTNERS REIT
DEA EASTERLY GOVERNMENT PROPERTIES INC
CDXS CODEXIS
ASA ASA
NEWT NEWTEK BUSINESS SERVICES INC.
ADC AGREE REALTY CORPORATION
CULP CULP INC.
FBK FB FINANCIAL CORPORATION
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
DMLP DORCHESTER MINERALS L.P.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
ZIVO ZIVO BIOSCIENCE
LOVE INC.
FUND LOVESAC
ETON ROYCE FOCUS TRUST
MCFT INC.
PGNY ETON PHARMACEUTICALS
DCTH MASTERCRAFT BOAT HOLDINGS
ENX PROGYNY
REYN DELCATH SYSTEMS
PRLD EATON VANCE NEW YORK MUNICIPAL BOND FUND
NOTV REYNOLDS CONSUMER PRODUCTS INC.
PFX PRELUDE THERAPEUTICS
XLO INOTIV
NVCT INC.
ANEB PHENIXFIN CORP
BHVN XILIO THERAPEUTICS INC
ACXP NUVECTIS PHARMA INC
BUKS ANEBULO PHARMACEUTICALS INC
ECBK BIOHAVEN LTD
GLSI ACURX PHARMACEUTICALS INC
MEGI BUTLER NATIONAL CORP
SCWO ECB BANCORP INC.
CVI GREENWICH LIFESCIENCES INC
SRFM MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
OCX 374WATER INC
SIRI CVR ENERGY
TXO INC.
MRKR SURF AIR MOBILITY INC.
TTGT ONCOCYTE CORPORATION
DTIL SIRIUS XM HLDGS INC NEW
AMST MORNINGSTAR PARTNERS
WHLM L.P.
MARKER THERAPEUTICS INC
TECHTARGET INC.
PRECISION BIOSCIENCES INC.
AMESITE INC.
WILHELMINA INTERNATIONAL INC
- Jonathan Moreland
- Jonathan Moreland
- Jonathan Moreland
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ETON ETON PHARMACEUTICALS
RLAY RELAY THERAPEUTICS
BIGZ BLACKROCK INNOVATION AND GROWTH TST
BUKS BUTLER NATIONAL CORP
GLSI GREENWICH LIFESCIENCES INC
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
MIO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
EVM EATON VANCE INSD CALIF MUN BD FD
- Jonathan Moreland
OXY OCCIDENTAL PETROLEUM CORPORATION
HPP HUDSON PACIFIC PROPERTIES INC.
VVI VIAD CORP
VRSN VERISIGN INC.
OMEX ODYSSEY MARINE EXPLORATION INC.
MMS MAXIMUS INC.
KVHI KVH INDUSTRIES INC.
FPI FARMLAND PARTNERS REIT
FDX FEDEX CORPORATION
DEA EASTERLY GOVERNMENT PROPERTIES INC
CDXS CODEXIS
ASA ASA
NEWT NEWTEK BUSINESS SERVICES INC.
ADC AGREE REALTY CORPORATION
CULP CULP INC.
PLSE PULSE BIOSCIENCES
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
DMLP DORCHESTER MINERALS L.P.
ZIVO ZIVO BIOSCIENCE
WHLM INC.
LOVE WILHELMINA INTERNATIONAL
FUND LOVESAC
MCFT ROYCE FOCUS TRUST
PGNY INC.
OXLC MASTERCRAFT BOAT HOLDINGS
ZYME PROGYNY
DCTH OXFORD LANE CAPITAL CORP.
REYN ZYMEWORKS INC.
PRLD DELCATH SYSTEMS
DLHC REYNOLDS CONSUMER PRODUCTS INC.
MASS PRELUDE THERAPEUTICS
NOTV DALEIGH HOLDINGS CORP
PFX 908 DEVICES
XLO INOTIV
NVCT INC.
ANEB PHENIXFIN CORP
BHVN XILIO THERAPEUTICS INC
BUKS NUVECTIS PHARMA INC
ECBK ANEBULO PHARMACEUTICALS INC
GLSI BIOHAVEN LTD
MEGI BUTLER NATIONAL CORP
SCWO ECB BANCORP INC.
SRFM GREENWICH LIFESCIENCES INC
OCX MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
SUNS 374WATER INC
SIRI SURF AIR MOBILITY INC.
TXO ONCOCYTE CORPORATION
MRKR SUNRISE REALTY TRUST
TTGT SIRIUS XM HLDGS INC NEW
KALA MORNINGSTAR PARTNERS
DTIL L.P.
MARKER THERAPEUTICS INC
TECHTARGET INC.
KALA BIO INC
PRECISION BIOSCIENCES INC.
- Jonathan Moreland
- Jonathan Moreland
CDXS CODEXIS
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
ANAB ANAPTYSBIO INC.
FUND ROYCE FOCUS TRUST
GRX INC.
ZYME THE GABELLI HEALTHCARE & WELLNESSRX TRUST
BIGZ ZYMEWORKS INC.
GLSI BLACKROCK INNOVATION AND GROWTH TST
MEGI GREENWICH LIFESCIENCES INC
TXO MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
MORNINGSTAR PARTNERS
L.P.
Savara Announces New Employment Inducement Grant
LANGHORNE, Pa.--(BUSINESS WIRE)-- (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to five new employees. On December 20, 2024, the Compensation Committee of Savara's Board of Directors granted the inducement awards to five new employees who recently joined the Company. The inducement awards consist of options to purchase an aggregate of 100,000 shares of the Company’s common stock and restricted stock units (RSUs) covering an aggregate of 100,000 shares of the Company’s common stock. These equity...
Savara Initiates Rolling Submission of a Biologics License Application...
LANGHORNE, Pa.--(BUSINESS WIRE)-- (Nasdaq: ) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, initiated a rolling submission of a BLA to the FDA for MOLBREEVI for the potential treatment of aPAP, a chronic and debilitating rare lung disease characterized by the abnormal build-up of surfactant in the alveoli of the lungs. MOLBREEVI was granted Fast Track and Breakthrough Therapy Designations in 2019 for the treatment of patients with aPAP. As a result, the Company is allowed to submit individual modules of the BLA as they are completed rather th...
Savara Announces Participation in the 43rd Annual J.P. Morgan Healthca...
LANGHORNE, Pa.--(BUSINESS WIRE)-- (Nasdaq: ) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the Company will present and host 1x1 meetings at the 43rd Annual J.P. Morgan Healthcare Conference. Date/Time of Presentation: January 15, 5:15pm PT/8:15pm ET Presenter: Matt Pauls, Chair and Chief Executive Officer, Savara Location: Westin St. Francis, San Francisco, Elizabethan C Room The live webcast and subsequent replay will be available on the “Events & Presentations” section of the Company’s corporate website at and will...
Universal Technical Institute Inc: 1 director
A director at Universal Technical Institute Inc sold 2,483,579 shares at 25.100USD and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Continue to Ride the Trend Higher Our outlook remains bullish and the significant end-of-year rally that we have been expecting since mid-October is in full swing; continue to ride the trend higher. Our election day Compass report (11/5/24) was titled "Buy the Pullback," and last week's Compass (11/19/24) was similarly titled "Buy the Pullback Again" considering our expectation for support at the 20-day MAs on the Russell 2000 (IWM), S&P 500, and Nasdaq 100 (QQQ) with small- and mid-caps likely...
VAC MARRIOTT VACATIONS WORLDWIDE CORPORATION
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
MAR MARRIOTT INTERNATIONAL INC. CLASS A
H HYATT HOTELS CORPORATION CLASS A
CHH CHOICE HOTELS INTERNATIONAL INC.
APEI AMERICAN PUBLIC EDUCATION
CCL CARNIVAL CORPORATION
LNC LINCOLN NATIONAL CORPORATION
UTI UNIVERSAL TECHNICAL INSTITUTE INC.
HGV HILTON GRAND VACATIONS INC.
LAUR LAUREATE EDUCATION INC. CLASS A
ATGE ADTALEM GLOBAL EDUCATION INC.
WH WYNDHAM HOTELS & RESORTS INC.
PRDO PERDOCEO EDUCATION CORP
LRN STRIDE INC
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
RMAX RE/MAX HOLDINGS INC.
OMER OMEROS CORPORATION
ELMD ELECTROMED
CRS CARPENTER TECHNOLOGY CORPORATION
CEVA CEVA INC.
AAOI APPLIED OPTOELECTRONICS INC.
SLM SLM CORP
UGI UGI CORPORATION
UTI UNIVERSAL TECHNICAL INSTITUTE INC.
MHH MASTECH DIGITAL
KINS KINGSTONE COS. INC.
PTGX PROTAGONIST THERAPEUTICS
TCMD TACTILE SYSTEMS TECHNOLOGY INC.
PDEX PRO-DEX INC.
FRMO FRMO CORPORATION
MMMB MAMAMANCINI'S HOLDINGS INC
REPL REPLIMUNE GROUP
BE BLOOM ENERGY
NEON NEONODE INC.
PWFL POWERFLEET INC
MRBK MERIDIAN
TPL TEXAS PACIFIC LAND CORPORATION
NPCE NEUROPACE INC
PLL PIEDMONT LITHIUM INC
SMR NUSCALE POWER CORP
RDW REDWIRE CORP
LUNR INTUITIVE MACHINES INC
HIPO HIPPO HLDGS INC
WGS GENEDX HOLDINGS CORP.
ASPI ASP ISOTOPES INC
AESI NEW ATLAS HOLDCO INC
NNE NANO NUCLEAR ENERGY
LB LANDBRIDGE COMPANY LLC
FOA FINANCE OF AMERICA COMPANIES INC.
DOGZ DOGNESS INTERNATIONAL CORP
TECX TD GLOBAL TECHNOLOGY LEADERS CAD HEDGED INDEX ETF
AZ A2Z CUST2MATE SOLUTIONS CORP
CDTX CIDARA THERAPEUTICS INC.
Greenwich LifeSciences Partners with GIM in Italy
Greenwich LifeSciences Partners with GIM in Italy STAFFORD, Texas, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced its partnership with clinical sites in Italy. The Company has partnered with "Gruppo Italiano Mammella" (GIM), the largest academic cooperative breast cancer research group in Italy, including over 150 participating centers and approx...
- Jonathan Moreland
RMAX RE/MAX HOLDINGS INC.
PSEC PROSPECT CAPITAL CORPORATION
PPSI PIONEER POWER SOLUTIONS
PBF PBF ENERGY INC. CLASS A
OPK OPKO HEALTH INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
MPAA MOTORCAR PARTS OF AMERICA INC.
GLP GLOBAL PARTNERS LP
EL ESTEE LAUDER COMPANIES INC. CLASS A
APPS DIGITAL TURBINE
ACRS ACLARIS THERAPEUTICS INC.
MEDP MEDPACE HOLDINGS INC.
ENPH ENPHASE ENERGY INC.
HTLD HEARTLAND EXPRESS INC.
RAIL FREIGHTCAR AMERICA INC.
SVRA SAVARA
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
ANGI ANGI INC. CLASS A
SNBR SLEEP NUMBER CORPORATION
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
MBIN MERCHANTS BANCORP
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
NOVA SUNNOVA ENERGY INTERNATIONAL
GRWG GROWGENERATION
PCB PACIFIC CITY FINANCIAL CORP
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
ONEW ONEWATER MARINE
BDSX BIODESIX
CSU CAPITAL SENIOR LIVING
MODV MODIVCARE INC
GRNT GRANIT SKOPKE
UAN CVR PARTNERS LP
INBX INHIBRX
OSCR INC.
WOLF OSCAR HEALTH
CLVT WOLFSPEED INC
ZETA CLARIVATE PLC
RWAY ZETA GLOBAL HLDGS CORP
CGBD RUNWAY GROWTH FINANCE CORP
NXGL TCG BDC
BIGZ INC.
DOUG NEXGEL INC
KLG_w BLACKROCK INNOVATION AND GROWTH TST
EP DOUGLAS ELLIMAN INC
MIO WK KELLOGG CO
MDRR EMPIRE PETROLEUM CORP
BNTC PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
EVM MEDALIST DIVERSIFIED REIT INC.
FGF BENITEC BIOPHARMA INC
EATON VANCE INSD CALIF MUN BD FD
FG FINANCIAL GROUP
INC.
Savara Announces New Employment Inducement Grant
LANGHORNE, Pa.--(BUSINESS WIRE)-- . (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to four new employees. On November 20, 2024, the Compensation Committee of Savara's Board of Directors granted the inducement awards to four new employees who recently joined the Company. The inducement awards consist of options to purchase an aggregate of 80,000 shares of the Company’s common stock and restricted stock units (RSUs) covering an aggregate of 70,000 shares of the Company’s common stock. These equity ...
Savara Announces Encore Presentation of Results from the Phase 3 IMPAL...
LANGHORNE, Pa.--(BUSINESS WIRE)-- (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that an encore presentation of results from the pivotal, Phase 3 IMPALA-2 trial will be presented at the British Thoracic Society (BTS) Winter Meeting, taking place November 27-29, 2024, in London, England. BTS Platform Presentation Details Title: “Inhaled Molgramostim Improves Pulmonary Gas Exchange and Respiratory Health-Related Quality of Life in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP): Results from IMPALA-...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.